Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 4, 2007, Pages 681-691

  Houston, Mark C ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hypertension Institute and Vacular Biology   (United States)

^c SAINT THOMAS HOSPITAL   (United States)

Author keywords

Antioxidants; Hypertension; Minerals; Nutraceutical supplements; Nutrition; Vascular biology; Vitamins

Indexed keywords

ACETYLCARNITINE; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CALCIUM; CELERY EXTRACT; DOCOSAHEXAENOIC ACID; GARLIC EXTRACT; ICOSAPENTAENOIC ACID; LYCOPENE; MAGNESIUM; MINERAL; MONOUNSATURATED FATTY ACID; NITRIC OXIDE; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; PLANT EXTRACT; POTASSIUM; PYCNOGENOL; PYRIDOXINE; TAURINE; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG; UNDARIA EXTRACT; UNINDEXED DRUG; VEGETABLE PROTEIN; VITAMIN;

ABSENCE OF SIDE EFFECTS; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CELERY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG USE; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION; HIGH POTASSIUM INTAKE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; LOW FAT DIET; OXIDATIVE STRESS; PATHOGENESIS; PRIMARY PREVENTION; PROTEIN DIET; QUALITY OF LIFE; RISK FACTOR; SODIUM RESTRICTION; STROKE; UNDARIA; VITAMIN SUPPLEMENTATION;

CALCIUM; COENZYMES; COMORBIDITY; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; GARLIC; HUMANS; HYPERTENSION; LIFE STYLE; MAGNESIUM; OXIDATIVE STRESS; POTASSIUM; SODIUM CHLORIDE; UBIQUINONE;

EID: 34447295618     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.4.681     Document Type: Article

References (59)

1. Bakris GL. A practical approach to achieving recommended blood pressure goals in diabetic patients. Arch. Intern. Med. 161, 2661-2667 (2001).
2. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA 289, 2560-2572 (2003).
3. Chobanian AV, Bakris GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252 (2003).
4. Eaton SB, Eaton SB 3rd, Konner MJ. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur. J. Clin. Nutr. 51, 207-216 (1997).
5. Weder AB. Your mother was right: eat your fruits and vegetables. Curr. Hypertens. Rep. 1, 11-12 (1999).
6. Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336, 1117-1124 (1997).
7. Ascherio A, Rimm EB, Hernan MA et al. Intake of potassium, magnesium, calcium and fiber and risk of stroke among US men. Circulation 98, 1198-1204 (1998).
8. De Lorgeril M, Salen P, Martin JL et al. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99, 779-785 (1999).
9. Resnick LM, Oparil S, Chait A et al. Factors affecting blood pressure responses to diet: the Vanguard Study. Am. J. Hypertens. 13, 956-965 (2000).
10. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N. Engl. J. Med. 344, 3-10 (2001).
11. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritional hygienic regimen along with various drug monotherapies. Arch. Intern. Med. 151, 1413-1423 (1991).
12. Himmelmarin A, Kjeldsen SE, Hedner T. Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC. Blood Press. 12, 196-197 (2003).
13. Guidelines Committee. 2003 European Society of Hypertension, European Society of Cardiology guidelines for the management of arterial hypertension. Hypertension 21, 1011-1053 (2003).
14. Houston MC. The role of vascular biology, nutrition and nutraceuticals in the prevention of hypertension. JANA Suppl. 1, 1-171 (2002).
15. Appel LJ. The role of diet in the prevention and treatment of hypertension. Curr. Atheroscler. Rep. 2, 521-528 (2000).
16. Whelton PK, He J. Potassium in preventing and treating high blood pressure. Semin. Nephrol. 19, 494-499 (1999).
17. Witteman JCM, Grobbee DE, Derk FHM et al. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. J. Clin. Nutr. 60, 129-135 (1994).
18. van Mierlo LA, Arends LR, Streppel MT et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J. Hum. Hypertens. 20, 571-580 (2006).
19. McCarron DA. Calcium metabolism in hypertension. Keio J. Med. 44, 105-114 (1995).
20. Preuss HG. Diet, genetics and hypertension. J. Am. Coll. Nutr. 16, 296-305 (1997).
21. Whiting SJ, Wood R, Kim K. Calcium supplementation. J. Am. Acad. Nurse Pract. 9, 187-192 (1997).
22. Elliott P, Dennis B, Dyer AR et al. Relation of dietary protein (total, vegetable, animal) to blood pressure: INTERMAP epidemiologic study. Presented at The 18th Scientific Meeting of the International Society of Hypertension. Chicago, IL, USA, 20-24 August 2000.
23. Kawase M, Hashimoto H, Hosoda M et al. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J. Dairy Sci. 83, 255-263 (2000).
24. Kawasaki T, Seki E, Osajima K et al. Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J. Hum. hypertens. 14, 519-523 (2000).
25. Bao DQ, Mori TA, Burke V et al. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 32, 710-717 (1998).
26. Knapp HR, Fitzgerald GA. The antihypertensive effects of fish oil: a controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med. 320, 1037-1043 (1989).
27. Morris M, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523-533 (1993).
28. Frisco D, Paniccia R, Bandinelli B et al. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb. Res. 91, 105-112 (1998).
29. Ferrara LA, Raimondi S, d'Episcopa I et al. Olive oil and reduced need for antihypertensive medications. Arch. Intern. Med. 160, 837-842 (2000).
30. Mohamadi A, Jarrell T, Shi SJ et al. Effects of wild versus cultivated garlic on blood pressure and other parameters in hypertensive rats. Heart Dis. 2, 3-9 (2000).
31. Silagy CA, Neil AN. A meta-analysis of the effect of garlic on blood pressure. J. Hypertens. 12, 463-468 (1994).
32. Ackermann RT, Muldow CD, Ramirez G. Garlic shows promise for improving some cardiovascular risk factors. Arch. Intern. Med. 161, 813-824 (2001).
33. Clouatre D. European Wild Garlic: The Better Garlic. Pax Publishing, CA, USA (1995).
34. Nakano T, Hidaka H, Uchida J et al. Hypotensive effects of wakame. J. Jpn Soc. Clin. Nutr. 20, 92 (1998).
35. He J, Welton PK. Effect of dietary fiber and protein intake on blood pressure. A review of epidemiologic evidence. Clin. Exp. Hypertens. 21, 785-796 (1999).
36. Duffy SJ, Gokce N, Holbrook M et al. Treatment of hypertension with ascorbic acid. Lancet 354, 2048-2049 (1999).
37. Fotherby MD, Williams JC, Forster LA et al. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J. Hypertens. 18, 411-415 (2000).
38. Ness AR, Chee D, Elliot P, Vitamin C and blood pressure - an overview. J. Hum. Hypertens. 11, 343-350 (1997).
39. Aybak M, Stermet A, Ayyildiz MO, Karakilcik AZ. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung 45, 1271-1273 (1995).
40. Paran E, Engelhard Y. Effect of tomato's lycopene on blood pressure, serum lipoproteins, plasma homocysteine and oxidative stress markers in grade I hypertensive patients. Am. J. Hypertens. 14, 141A (2001) (Abstract p-333).
41. Khosh F. Hypertension and co-enzyme Q10. Altern. Med. Rev. 1(3), 171-174 (1996).
42. Digiesi V, Cantini F, Bisi G et al. Mechanism of action of coenzyme Q10 in essential hypertension. Curr. Ther. Res. 51, 668-672 (1992).
43. Digiesi V, Cantini F, Brodbeck B. Effect of coenzyme Q10 on essential hypertension. Curr. Ther. Res. 47, 841-845 (1990).
44. Digiesi V, Cantini F, Oradei A et al. Coenzyme Q-10 in essential hypertension. Mol. Aspects Med. 15, 8257-8263 (1994).
45. Kendler BS. Nutritional strategies in cardiovascular disease control: an update on vitamins and conditionally essential nutrients. Prog. Cardiovasc. Nurs. 14, 124-129 (1999).
46. Langsjoen P, Willis R, Folkers K. Treatment of essential hypertension with coenzyme Q10. Mol. Aspects Med. 15, 8265-8272 (1994).
47. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q-10 in isolated systolic hypertension. South. Med. J. 94, 1112-1117 (2001).
48. Kelly JJ, Williamson P, Martin A, Whitworth JA. Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol-treated humans. J. Hypertens. 19, 263-268 (2001).
49. Siani A, Pagano E, Iacone R et al. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am. J. Hypertens. 13, 547-551 (2000).
50. Ando K, Fujita T. Etiological and physiopathological significance of taurine in hypertension. Nippon Rinsho 50, 374-381 (1992).
51. Fujita T, Ando K, Noda H et al. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75, 525-532 (1987).
52. Castleman M. The healing herbs. In: The Ultimate Guide to the Curative Power of Nature's Medicines. Rodale Press, Emmaus, PA, USA 105-107 (1991).
53. Duke JA. The Green Pharmacy Herbal Handbook. Rodale Press, Emmaus, PA, USA 68-69 (2000).
54. Heinerman J. Heinerman's New Encyclopedia of Fruits and Vegetables. Prentice Hall, NJ, USA 93-95 (1995).
55. Le OT, Elliott WJ. Dose response relationship of blood pressure and serum cholesterol to 3-N-butyl phthalide, a component of celery oil. Clin. Res. 39, 750A (1991) (Abstract).
56. Le OT, Elliott WJ. Mechanisms of the hypotensive effect of 3-N-butyl phthalide (BUPH): a component of celery oil. J. Am. Hypertens. 40, 326A (1992) (Abstract).
57. Hosseini S, Lee J, Sepulveda RT et al. A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutr. Res. 21, 1251-1260 (2001).
58. McMackin CJ, Widlansky ME, Hamburg NM et al. Effect of combined treatment with α-lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease. J. Clin. Hypertens. 9, 249-255 (2007).
59. Galley HF, Thornton J, Howdle PD et al. Combination oral antioxidant supplementation reduces blood pressure. Clin. Sci. 92, 361-365 (1997).